Biomarkers to phenotype COPD: prediction of exacerbations

E-poster
Chairs: Z. Lázár (Budapest, Hungary), P. Burgel (Paris, France)
Aims: This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.

Proteobacteria phylum association with airway- and emphysema-dominant COPD phenotypes defined by computed tomography M. Yavari Ramsheh (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), D. Subramanian (Derby, United Kingdom), D. Parr (Coventry, United Kingdom), L. Ziegler-Heitbrock (Gauting, Germany), I. Gut (Barcelona, Spain), D. Singh (Manchester, United Kingdom), C. Brightling (Leicester, United Kingdom)
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study B. Ding (Gothenburg, Sweden), R. Zaha (Bethesda, MD, United States of America), M. Ishida (Osaka, Japan), S. Graham (London, United Kingdom), A. Hayashi (Osaka, Japan), S. Huse (Bethesda, MD, United States of America), H. Müllerová (Cambridge, United Kingdom), S. Muro (Nara, Japan)
Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease T. Vitkina (Vladivostok, Russian Federation), . Sidletskaya (Vladivostok, Russian Federation), Y. Denisenko (Vladivostok, Russian Federation)
Fat-Free Mass Index and functional limitation in COPD S. Mariam (Sfax, Tunisia), K. Khouloud (Sfax, Tunisia), H. Asma (Sfax, Tunisia), C. Sahar (Sfax, Tunisia), M. Kaouthar (Sfax, Tunisia)
Is there an endotype to the treatable eosinophilic trait of chronic obstructive pulmonary disease (COPD) O. Walsh (Shropshire, United Kingdom), M. Marathe (Shropshire, United Kingdom), H. Moudgil (Shropshire, United Kingdom), K. Srinivasan (Shropshire, United Kingdom), E. Crawford (Shropshire, United Kingdom), A. Makan (Shropshire, United Kingdom), N. Ahmad (Shropshire, United Kingdom)
Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD N. Obling (Næstved, Denmark), B. Rangelov (London, United Kingdom), V. Backer (Copenhagen, Denmark), J. Hurst (London, United Kingdom), U. Bodgter (Næstved, Denmark)
Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. C. Tirelli (Pavia, Italy), S. Ottaviani (Pavia, Italy), D. Piloni (Pavia, Italy), V. Barzon (Pavia, Italy), A. Balderacchi (Pavia, Italy), D. Ambruoso (Pavia, Italy), A. Corino (Pavia, Italy), F. Mariani (Pavia, Italy), I. Ferrarotti (Pavia, Italy), A. Corsico (Pavia, Italy)
The Correlation Between COPD Severity and The Left Ventricular Function j. Ben Halima (Tunis, Tunisia), A. Saidane (Tunis, Tunisia), E. Ben Jemai (Tunis, Tunisia), M. Ben Halima (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort N. Faria (Porto, Portugal), M. Costa (Porto, Portugal), J. Gomes (Porto, Portugal), M. Sucena (Porto, Portugal)
COPD phenotypes on computed tomography and its relationship with exercise and ventilatory function L. Valente Marques Sousa Gomes (Coimbra, Portugal), S. Rodrigues Sousa (Coimbra, Portugal), J. Nunes Caldeira (Coimbra, Portugal), S. Pereira (Coimbra, Portugal), A. Tenda Cunha (Coimbra, Portugal), I. Farinha (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal)
Brainstem auditory evoked potential in COPD patients : a comparative study a. haddaar (Sfax, Tunisia), I. Kammoun (Sfax, Tunisia), R. Kammoun (Sfax, Tunisia), K. Kchaou (Sfax, Tunisia), G. Sakly (Sousse, Tunisia), K. Masmoudi (Sfax, Tunisia)
Nutritional status in patients with chronic obstructive pulmonary disease - a first multi-centre experience in Croatia D. Mursic (Zagreb, Croatia), T. Jalusic Gluncic (Zagreb, Croatia), J. Ostojic (Zagreb, Croatia), S. Skrinjaric-Cincar (Osijek, Croatia), L. Bulat Kardum (Rijeka, Croatia), M. Dokoza (Zadar, Croatia), A. Rozman (Zagreb, Croatia), N. Karamarkovic Lazarusic (Zagreb, Croatia), E. Besic (Zagreb, Croatia), M. Samarzija (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia)
Are there correlations between composite indexes and quality of life in COPD? DOSE vs ADO K. Kchaou (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), S. Chakroun (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), S. Jameleddine (Ariana, Tunisia)
Association of GDF-15 with 6 minute walking test. C. Amado Diago (Santander (Cantabria), Spain), P. Martín Audera (Santander (Cantabria), Spain), D. Boucle Tirador (Santander (Cantabria), Spain), M. García-Unzueta (Santander (Cantabria), Spain), M. Ruiz De Infante Pérez (Santander (Cantabria), Spain), A. Berja (Santander (Cantabria), Spain), A. Guerra (Santander (Cantabria), Spain), B. Lavin (Santander (Cantabria), Spain), S. Izquierdo Cuervo (Santander (Cantabria), Spain), G. Andretta (Santander (Cantabria), Spain), M. Cristeto (Santander (Cantabria), Spain), J. Osorio Chaves (Santander (Cantabria), Spain), L. González (Santander (Cantabria), Spain), N. Borja Vargas (Santander (Cantabria), Spain), J. Agüero (Santander (Cantabria), Spain), D. Ferrer Pargada (Santander (Cantabria), Spain), B. Josa Laorden (Santander (Cantabria), Spain)
Maximal respiratory pressures in COPD: What are the influencing factors? R. Barros (Lisboa, Portugal), L. Raposo (Lisboa, Portugal), N. Moreira (Lisboa, Portugal), M. Rocha (Lisboa, Portugal), P. Calaça (Lisboa, Portugal), I. Spencer (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients P. Sobradillo Ecenarro (Bilbao (Bizkaia), Spain), N. Marina (Bilbao (Bizkaia), Spain), S. Pérez-Fernández (Barakaldo, Spain), E. Tabernero (Bilbao (Bizkaia), Spain), M. Iriberri (Bilbao (Bizkaia), Spain), B. Celli (Boston , United States of America)
Distance estimation and functional distance perception in patients with Chronic Obstructive Lung Disease (COPD). A. O'Mahony (Dublin, Ireland), B. Nolan (Dublin, Ireland), A. Mcdonough (Dublin, Ireland), E. Kelly (Dublin, Ireland)
Characterization of lung volumes in COPD L. Raposo (Lisboa, Portugal), R. Barros (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
Is FEV1/FEV6 ratio a reliable  tool in COPD diagnosis ? S. Chakroun (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)